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MCM-41 anchored n-propylamine (MCM-41-nPrNH2) was found to be a highly efficient and recoverable 
nanocatalyst for the synthesis of new class of phenylpyrido[4,3-d]pyrimidin-2-amine derivatives under 
solvent free conditions in high to quantitative yields. All the structures of title compounds 3a-j were 
elucidated by comprehensive 1H NMR, 13C NMR, IR and Mass spectra 
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1. INTRODUCTION 
 
MCM-41 (Mobil Composition of Matter No. 41) is a 
mesoporous material and consists of a hexagonal array 
of unidirectional pore structures which has been synthe-
sized under basic condition using cationic surfactants as 
a structure-directing agent. Pure MCM-41 is neutral in 
charge and exhibits only weak hydrogen-bonding type 
sites which limit its application in catalysis [1-5]. An 
additional possibility to develop basic catalysts is modifi-
cation of supports, as the chemical functionalities of the-
se materials can be uniformly achieved by covalent an-
choring of different organic moieties[ 6]. One of the modi-
fied organic-inorganic hybrid materials that have been 
applied as effective solid base catalyst in organic trans-
formations is 3-aminopropylated silica (MCM-41-
nPrNH2) [7-10]. The functional aminopropyl group was 
anchored on MCM-41 silica by the post-modification 
which was prepared according to the method reported in 
the literature from the reaction of MCM-41 with 3-
aminopropyltriethoxysilane in refluxing toluene [11]. 
The use of heterogeneous solid base catalysts is of 
current interest in chemistry and industry because 
solid bases offer many advantages such as simplicity in 
handling, more environmentally safe disposal and less 
corrosion problems.  
Pyrido[4,3-d]pyrimidines display various remarka-
ble biological activities such as antibacterial [12], an-
tiallergic [13], fungicidal, antiviral, anti-inflammatory, 
and antimicrobial properties [14-19]. Inhibition of the 
adenosine kinase enzyme [20], or dihydrofolate reduc-
tase, and irreversible inhibition of epidermal growth 
factor receptor [21], stimulated our interest immensely. 
Also, 5, 6, 7, 8-tetrahydropyrido[4,3-d]pyrimidine and 
related compounds have been used as starting materi-
als for the multi-step synthesis of tetrahydropteroic 
acid derivatives [22]. 
In view of the useful properties of pyrido[4,3-
d]pyrimidines and to the best of our knowledge there 
are no reports for the synthesis of phenylpyrido[4,3-
d]pyrimidin-2-amines in the literature. Hence, follow-
ing our immense desire to adopt rather greener and 
economical reaction conditions [23], herein, we report 
an efficient synthesis of 3 and its derivatives through the 
two component reactions between (E)-3,5-bis(benzyl-
idene)-4-piperidones (1) and benzamidine hydrochloride 
(2) in the presence of recoverable catalyst (MCM-41-
nPrNH2) under solvent free conditions (Fig. 1). 
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Fig. 1 – Synthesis of phenylpyrido[4,3-d]pyrimidin-2-amine 
derivatives in the presence of MCM-41-nPrNH2 
 
2. RESULTS AND DISSCUSSIONS 
 
After optimization of the reaction condition, a varie-
ty of aromatic aldehydes, possessing both electron-
donating and electron-withdrawing groups were em-
ployed for phenylpyrido[4,3-d]pyrimidin-2-amine for-
mation and the results indicated that for 3,5-
dibenzylidenepiperidin-4-one bearing different func-
tional groups, the reaction proceeded smoothly in all 
cases. It is worth mentioning that 3,5-dibenzyl-
idenepiperidin-4-one with electron-withdrawing groups 
reacted rapidly whereas with those having electron-
rich groups, longer reaction times were required. Elec-
tron-withdrawing groups on the phenyl rings induce 
greater electronic positive charge on the corresponding 
β-atoms than electron donating moieties.  
 
3. EXPERIMENTALS 
 
3.1 General remarks 
 
Melting points were recorded on a Buchi B-540 ap-
paratus. IR spectra were recorded on an ABB Bomem 
Model FTLA200-100 instrument. 1H and 13CNMR spec-
tra were measured on a Bruker DRX-300 spectrometer, 
at 300 and 75MHz, using TMS as an internal standard. 
Chemical shifts (δ) were reported relative to TMS, and 
coupling constants (J) were reported in hertz (Hz). 
Mass spectra were recorded on a Shimadzu QP 1100 
EX mass spectrometer with 70-eV ionization potential. 
 SHAHNAZ ROSTAMIZADEH, NASRIN SHADJOU, ELYASS ISAPOOR PROC. NAP 1, 02NNBM18 (2012) 
 
 
02NNBM18-2 
3.2 Preparation of MCM-41-nPrNH2 
 
Functionalized catalyst (MCM-41-nPrNH2) was pre-
pared according to the method reported in the literature 
from the reaction of MCM-41 with 3-aminopropyl-
triethoxysilane in refluxing toluene [11] (Fig. 2) 
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Fig. 2 – Functionalization of the MCM-41with 3-aminopropyl-
triethoxysilane 
 
3.3 General procedure for the synthesis of 3,5-
dibenzylidenepiperidin-4-one 
 
In a 50-mL reaction vial, a mixture of the 4-
piperidone (10 mmol), the appropriate aldehyde (20 
mmol), 10% NaOH (1 mL) and 95% EtOH (30 mL) was 
stirred at room temperature for 0.5-2 h. The separated 
solid was collected by filtration and for further purifica-
tion was recrystallized from ethanol [19]. 
 
Table 1 – The reaction time (min) and the yield (%) of 
phenylpyrido[4,3-d]pyrimidin-2-amine product in the present 
of MCM-41-nPrNH2 
 
Entry Product Time 
(min) 
Yield* 
(%) 
M.P (οC) 
Found 
3a 4Cl-C6H4- 30 8 240-242 
3b 2,4diCl-C6H3- 30 80 206-208 
3c 2Cl-C6H4- 30 98 146-148 
3d 2,3diCl-C6H3- 30 89 156-158 
3e 3-NO2-C6H4- 30 95 228-230 
3f 4-NO2-C6H4- 20 98 >300 
 
3.4 General procedure for the synthesis of 4-phenyl-
pyrido[4,3-d]pyrimidin-2-amine derivatives 
 
A mixture of 3,5-dibenzylidenepiperidin-4-one (0.33 
mmol), and guanidine carbonate (0.33 mmol) was add-
ed to MCM-41-nPrNH2 (30 mg); it was then stirred at 
130 °C for an appropriate period of time (Table 1). After 
completion of the reaction (monitored by thin-layer 
chromatography, TLC; petroleum ether and EtOAc, 
1:1), the reaction mixture was cooled to room tempera-
ture a minimum amount of ethylacetate was added, 
and the nanocatalyst recovered. The extract was con-
centrated under reduced pressure and purified by re-
crystallization in 1:1 EtOH /H2O.  
 
(8E)-8-(4-chlorobenzylidene)-4-(4-
chlorophenyl)-3,4,5,6,7,8-hexahydro-6-
methylpyrido[4,3-d]pyrimidin-2-amine (3a) 
 
IR (KBr, cm-1) Vmax: 3381, 3251, 3154, 2970, 1646, 
1458; 1HNMR (300 MHz; DMSO- d6): 2.06 (3H, s, N-
CH3), 2.42 (1H, d, J=16.0 Hz), 2.80 (1H, d, J=16.0 Hz), 
3.00 (1H, d, J=13.5 Hz), 3.37 (1H, d, J=14.1 Hz), 4.51 
(1H, s), 7.23-7.56 (12H, m); 13CNMR (75 MHz, DMSO-
d6): 44.8, 109.6, 119.2, 128.3, 128.8, 129.0, 130.6, 132.8. 
(8E)-8-(2,4-dichlorobenzylidene)-4-(2,4-
dichlorophenyl)-3,4,5,6,7,8-hexahydro-6-
methylpyrido[4,3-d]pyrimidin-2-amine (3b) 
 
IR (KBr, cm-1) Vmax: 3383, 3255, 3157, 2972, 1647, 
1452; 1HNMR (300 MHz; DMSO- d6): 2.11 (3H, s, N-
CH3), 2.55 (1H, d, J=16.0 Hz), 2.85 (1H, d, J=16.0 Hz), 
3.00-3.24 (2H, m), 4.35 (1H, s), 5.28 (1H, s), 5.38 (1H, 
s), 6.64 (1H, brs), 7.20 (1H, s), 7.23 (1H, d, J=8.4 Hz), 
7.38 (2H, dd, J1=8.1, J2=3.1 Hz), 7.50 (1H, dd, J1=8.3, 
J2=2.0 Hz), 7.59 (2H, dd, J1=8.3, J2=2.0 Hz); 13CNMR 
(75 MHz, DMSO- d6): 45.1, 52.3, 55.1, 56.0, 107.9, 
117.3, 127.0, 128.3, 128.6, 128.7, 130.9, 131.6, 131.9, 
132.0, 132.8, 133.7, 134.4, 134.6, 135.5, 140.4, 152.3 ; 
MS (EI): m/e = 57 (4), 258 (19), 292 (60), 309 (17), 366 
(17), 366 (23), 431 (55), 465 (100), 468 (38). 
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